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The L-2-haloacid dehalogenase from the 1,2-dichloro-
ethane degrading bacterium Xanthobacter autotrophi-
cus GJ10 catalyzes the hydrolytic dehalogenation of
small L-2-haloalkanoic acids to yield the corresponding
D-2-hydroxyalkanoic acids. Its crystal structure was
solved by the method of multiple isomorphous replace-
ment with incorporation of anomalous scattering infor-
mation and solvent flattening, and was refined at 1.95-Å
resolution to an R factor of 21.3%. The three-dimensional
structure is similar to that of the homologous L-2-halo-
acid dehalogenase from Pseudomonas sp. YL (1), but the
X. autotrophicus enzyme has an extra dimerization do-
main, an active site cavity that is completely shielded
from the solvent, and a different orientation of several
catalytically important amino acid residues. Moreover,
under the conditions used, a formate ion is bound in the
active site. The position of this substrate-analogue pro-
vides valuable information on the reaction mechanism
and explains the limited substrate specificity of the Xan-
thobacter L-2-haloacid dehalogenase.
The bacterium Xanthobacter autotrophicus is capable of
growing on short-chain haloalkanes as its sole source of carbon
and energy (2). Its natural substrate 1,2-dichloroethane is de-
graded via 2-chloroethanol, chloroacetaldehyde, and chloroac-
etate to glycolate in four successive enzymatic reactions before
it enters the organism’s central metabolic routes. Brominated
compounds can also be processed in this way. Two different
dehalogenases are used to cleave off the halogen atoms in the
first and fourth step. In the first step, a haloalkane dehaloge-
nase catalyzes the conversion of 1,2-dichloroethane into 2-chlo-
roethanol and chloride. The three-dimensional structure (3)
and catalytic mechanism (4) of this enzyme have been eluci-
dated by x-ray crystallography.
In the fourth degradation step, a 2-haloacid dehalogenase
catalyzes the conversion of chloroacetate to glycolate and chlo-
ride. Over 20 different 2-haloacid dehalogenases (EC 3.8.1.2)
have been found in various bacteria (5). They have been
grouped into four different classes according to their substrate
specificity and stereospecific action on 2-monochloropropionic
acid: two classes of enzymes that are active with only the L- or
D-substrate, yielding products with inversion of configuration
at the chiral C-2 carbon atom. The two other classes act on both
stereo-isomers, one with inversion of configuration, the other
with retention. High amino acid sequence identities are ob-
served among the dehalogenases within any of the separate
classes (6, 7), but no homology is evident between the 2-haloa-
cid dehalogenases from different classes.
The 2-haloacid dehalogenase from X. autotrophicus belongs
to the class of L-specific dehalogenases that act with inversion
of configuration (L-DEXs).1 The dhlB gene encoding for it was
cloned and sequenced, and the enzyme (DhlB) has been puri-
fied and characterized (8). The protein consists of a single
polypeptide chain of 253 amino acids and has a molecular mass
of 27,431 Da. The amino acid sequence is over 40% identical to
seven other L-2-haloacid dehalogenases from various Pseudo-
monas species and one haloacetate dehalogenase from Morax-
ella sp. strain B (9). It shows no homology to haloalkane deha-
logenase from X. autotrophicus or 4-chlorobenzoyl-coenzyme A
dehalogenase from Pseudomonas sp. CBS-3 (10), the two other
dehalogenases structurally characterized so far.
Dehalogenases act on halogenated aliphatic compounds,
which are industrially applied on a large scale as solvents, as
intermediates in the production of plastics, and as insecticides.
They cause severe problems due to their toxicity as well as
their persistence in the environment (11). Since dehalogenases
can be used in a biotechnological approach to detoxify these
environmentally damaging compounds, they are a fascinating
target for research. In addition, the stereospecificity of L-DEXs
could make them useful for the biosynthesis of chiral 2-hy-
droxyalkanoic acids.
18O-Labeled H2O incorporation experiments have indicated
that the dehalogenation reaction catalyzed by L-2-haloacid de-
halogenase from Pseudomonas sp. YL (L-DEX YL) proceeds via
a two-step mechanism, with Asp10 acting as a nucleophile in
the first step (12). From site-directed mutagenesis, Kurihara et
al. (9) identified eight other amino acid residues involved in
catalysis and substrate binding. Recently, the structure of the
L-DEX YL was solved to 2.5-Å resolution (1), which showed that
the enzyme has a mixed a/b core domain in a Rossmann-type
fold with a four-helix bundle subdomain insertion. The homol-
ogous DhlB has 102 out of its 253 amino acid residues in
common with the L-DEX YL sequence. To gain more insight
into the factors that determine the substrate specificity and
stereospecific catalysis, to obtain a structure-based model for
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the reaction mechanism, and to complement the data already
obtained on the Pseudomonas enzyme, we extended our crys-
tallographic studies on dehalogenating enzymes to the L-2-
haloacid dehalogenase from X. autotrophicus. Here we present
the 1.95-Å structure of the enzyme with the substrate-analogue
formate bound in the active site, from which a structure-based
substrate binding model and the enzyme’s reaction mechanism
are inferred.
EXPERIMENTAL PROCEDURES
Dynamic Light Scattering—The oligomerization state of L-2-haloacid
dehalogenase in solution was determined by dynamic light scattering
analysis on a DynaPro 801 instrument (Protein Solutions, Charlottes-
ville, VA), applying 0.1-mm filters for sample injection. A solution of 3.3
mg/ml protein in 100 mM bis-Tris 1 Tris buffer, pH 7.0, was monitored
at 22 °C, with or without the presence of 200 mM sodium formate.
Apparent molecular masses of the enzyme as well as the percentage
polydispersity were calculated with the instrumentation software using
the monomodal assumption. In the absence of formate, the molecular
mass fluctuated around 60 kDa (polydispersity of 35%) with deviations
up to 20 kDa. The addition of sodium formate reduced the apparent
hydrodynamic radius of the molecule, resulting in an estimated molec-
ular mass of 50 kDa (polydispersity 27%) with deviations of about 10
kDa. Subsequent incubation with formate for 1 h lowered the apparent
molecular mass to 45 kDa with a corresponding polydispersity of 23%.
The fluctuations were reduced to 2–3 kDa and 1–2%, respectively. In a
gel filtration experiment with the equilibrated protein solution using a
Superdex 75 PC 3.2/30 column (Pharmacia, Sweden), the molecular
mass was measured to be 50 kDa.
Crystallization and Heavy Atom Derivative Search—L-2-Haloacid de-
halogenase was purified and crystallized as described previously (8, 13).
Rod-shaped crystals (typical size 0.4 3 0.15 3 0.15 mm3) were obtained
within a few weeks at room temperature by vapor diffusion in hanging
drops using macro-seeding techniques. The drop contained 6 ml 2.5
mg/ml protein, 16% (w/v) PEG 8000, 200 mM sodium formate, and 100
mM bis-Tris buffer, pH 6.8–7.0. The well contained 1 ml of 20–22% PEG
8000, 200 mM sodium formate, and 100 mM bis-Tris buffer, pH 6.8–7.0.
The crystals belonged to space group C2221, with cell axes a 5 57.2 Å,
b 5 91.5 Å, c 5 84.1 Å for data collected at 120 K (native 1). The crystal
volume per unit mass, VM, was 2.00 Å
3/Da, assuming one molecule in
the asymmetric unit. The deduced solvent content was 38%. Under the
same conditions also crystals belonging to space group P212121 were
found, with cell axes a 5 57.2 Å, b 5 84.2 Å, c 5 91.5 Å for data collected
at 100 K (native 2). Crystals in both crystal forms were of good x-ray
quality and diffracted up to 2.0-Å resolution, when synchrotron radia-
tion was used.
Heavy atom derivatives were prepared by soaking the crystals in
solutions of a standard mother liquor, containing 25% PEG 8000, 200
mM sodium formate, and 100 mM bis-Tris buffer, pH 6.8–7.0. The pH,
heavy atom concentration, and soaking time were varied for promising
compounds. In this way, over 25 different compounds were tested under
various conditions. X-ray diffraction data were collected at room tem-
perature to check for heavy atom binding. None of the compounds tried
yielded a usable derivative, mainly due to problems with non-isomor-
phism. However, after switching to data collection at cryogenic temper-
atures, the search readily resulted in four isomorphous derivatives.
These were prepared by soaking native crystals for 2 days in 3 mM
K2OsO4, for 3 days in 1 mM p-chloromercuribenzene sulfonate (PC-
MBS), for 1.5 days in 3 mM ethyl mercurithiosalicylate, and for 4 days
in 3 mM IrCl3, respectively. Addition of 25% glycerol to the mother
liquor yielded a good cryoprotectant for cryogenic data collection.
Data Collection and Processing—Diffraction data for two native and
six derivative data sets were collected in house and at the synchrotron
beamlines of the EMBL Outstation at DESY, Hamburg, Germany (see
Table I). The in-house data sets (native 1 and the ethyl mercurithiosa-
licylate and IrCl3) were collected from single crystals at 120 K on an
Enraf Nonius FAST area detector system (Enraf Nonius, Delft, The
Netherlands). The detector was equipped with a CAD4 k-goniostat with
graphite monochromatized CuKa radiation (l 5 1.5418 Å) from an
Elliot GX21 rotating anode x-ray generator. These data were collected
and processed using the MADNES package (14). Profile fitting and local
scaling of the data was done according to Kabsch (15), and afterward
the data were merged with software from the BIOMOL crystallographic
package (Protein Crystallography Group, University of Groningen).
All synchrotron data were collected at the beamlines of the EMBL
Outstation at DESY, Hamburg, at cryotemperatures (100 K) from sin-
gle crystals. The osmate and PCMBS derivative data were collected at
the X31 beamline, equipped with an 18-cm MAR image plate area
detector (MAR Research, Hamburg, Germany), with wavelengths tuned
to lOs 5 0.945 Å, and l2-PCMBS 5 1.006 Å, respectively, to make optimal
use of anomalous scattering. For the mercury derivative, data sets at
l1-PCMBS 5 1.009 Å and l3-PCMBS 5 0.845 Å were also collected to
attempt phasing by the method of multiple wavelength anomalous
diffraction. A high resolution native data set (native 2) was taken at the
BW7B beamline (l 5 0.883 Å), equipped with a 30-cm MAR image plate
area detector. However, the crystal used belonged to space group
P212121, which was different from the C2221 crystals observed before.
All synchrotron data were integrated and merged with DENZO/
SCALEPACK (16). Derivative data were scaled to the native 1 data set
with PHASES (17). Data processing statistics are given in Table I.
Structure Determination and Refinement—The structure was ini-
tially solved in space group C2221 by the method of multiple isomor-
phous replacement in combination with anomalous scattering informa-
tion from all derivatives (MIRAS). All calculations pertaining to the
MIRAS analysis and subsequent density modification were done with
the PHASES program package. Isomorphous and anomalous difference
Patterson maps (10–4 Å data) for the osmate derivative showed a clear
single heavy atom site. The resulting phase information was used to
calculate isomorphous and anomalous cross-difference Fourier maps for
the PCMBS derivative, yielding a single major site. From this, the other
two heavy atom data sets could easily be interpreted. For both mercury
derivatives, minor sites were identified from difference Fourier maps in
the course of the phase refinement. Concerning the three PCMBS data
sets, isomorphous differences from only the l3-PCMBS data were used.
Anomalous information from all three PCMBS data sets was included.
The final figure of merit was 0.72 for data up to 3.0 Å. Phasing statistics
are given in Table I. The MIRAS maps were further improved by
solvent flattening, assuming a solvent content of 35%, and by phase
extension to 3.0-Å resolution to include calculated intensities for the
missing reflections.
This final 3.0-Å resolution electron density map was traced using O
(18), and nearly all the chain could be interpreted according to the
amino acid sequence (8). One dubious loop connecting two strands was
removed after inspection of the L-DEX YL structure that had just been
published (1). Molecular replacement routines from AMoRe (19) were
then applied to position two copies of the C2221 model in the P212121
cell. A random set of 5% of the unique reflections was set apart to
calculate Rfree values (20) as an independent validation of the refine-
ment process. The model was subjected to simulated annealing refine-
ment (4000 3 300 K) with X-PLOR (21) with non-crystallographic
symmetry constraints. Subsequent cycles of REFMAC (22) and ARP
(23) were used in positional and B factor refinement and to automati-
cally place solvent molecules. In the first cycles, tight restraints on
non-crystallographic symmetry were applied, but these were gradually
released and in later stages the molecules were refined independently
since this gave the lowest Rfree values. At all stages, sA-weighted OMIT
2Fo 2 Fc electron density maps (24–26) were calculated and inspected
with O to check the agreement of the model with the data. PROCHECK
(27) was used to assess the stereochemical quality. Whenever neces-
sary, the model was manually adjusted in O. When the refinement gave
no further decrease in Rfree nor any improvement in stereochemistry, it
was considered completed. The initial Rwork factor was 44.1% (Rfree 5
44.7%) for data in the range of 7–2.0-Å resolution. After refinement, the
Rwork factor had improved to 19.0% for data ranging from 5.0 to 1.95 Å
(Rfree 5 24.8%). A final round of refinement including all data resulted
in an overall crystallographic R factor of 21.3% for data ranging from
15.0 to 1.95 Å. The final model consists of 3776 protein atoms, 3 formate
ions, and 334 water molecules. Refinement statistics are given in Table
II. The structure was analyzed using the programs GRASP (28), ASC
(29), VOIDOO (30), and programs from the CCP4 suite (31) and the
BIOMOL package. The atomic coordinates and structure factor ampli-
tudes have been deposited in the Brookhaven Protein Data Bank with
the entry code 1aq6.
RESULTS AND DISCUSSION
Accuracy of the Model—The three-dimensional structure of
L-2-haloacid dehalogenase from X. autotrophicus was solved by
multiple isomorphous replacement supplemented with anoma-
lous scattering information. The refined structure consists of
two copies of the molecule, comprising amino acids 1–245 for
both monomers. Three formate ions and 334 water molecules
are also contained in the structure. For both molecules, the
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C-terminal residues 246–253 are not included, because the
electron density was too weak to identify their positions unam-
biguously. In both molecules, the amino acid residue at position
84, a glycine according to the sequence, has clear extra forked
electron density extending from Ca, allowing for a Leu, Asn, or
Asp. Since it is on the outside of the protein and the Fo 2 Fc
electron density is flat, it can be either an asparagine or an
aspartate residue. On the basis of on the DNA sequence (GGG
for Gly (8), GA(U/C) for Asp, and AA(A/U) for Asn), we have
chosen to model in an aspartate. All other regions of both
molecules fit the electron density very well (Fig. 1), as is also
reflected in the average real-space correlation coefficient of
0.86 for the final sA-weighted OMIT 2Fo 2 Fc electron density
map. In two short loops and the C terminus in both molecules
(residues 25–27, 204–206, and 244–245), the main chain seems
to be disordered and only one of the possible conformations for
each loop is represented in the model.
A comparison of the two independently refined dehalogenase
molecules in the asymmetric unit shows r.m.s. differences of
0.30 Å on Ca atoms, which is above the coordinate error of 0.2
Å as estimated from a Luzzati plot (32) (data not shown).
However, an important part of these differences occurs in the C
terminus and the two short loops that seem to be moderately
disordered. Another major contribution stems from two short
loops, residues 105–107 and 126–132, on the outside of the
protein. This is due to their different environment in the two
monomers, caused by different crystal contacts in these two
regions. Leaving these loops out of the comparison results in an
r.m.s. difference of 0.19 Å for 225 superimposed Ca atoms.
Thus, the small variations between the two molecules in the
asymmetric unit must be attributed to conformational flexibil-
ity and/or a different crystal environment of regions on the
outside of the dimer rather than to biologically significant
structural differences between the monomers. All results dis-
cussed below apply to both molecules, unless stated otherwise.
The crystallographic R factor is 21.3% for data in the reso-
lution range of 15–1.95 Å. In a Ramachandran plot (not shown)
93.9% of the residues are in the most favored regions, while the
remaining 6.1% lie in the additionally allowed parts. The over-
all G factor from PROCHECK is 10.10, and the r.m.s. devia-
tions from ideal geometry are 0.009 Å and 2.1° for bond lengths
and angles, respectively (33). The average B value for all pro-
tein atoms is 20.7 Å2 and 31 Å2 for non-protein atoms. Thus, it
can be safely concluded that the geometry of the model is
sound.
Protein Structure—The L-2-haloacid dehalogenase molecule,
with approximate dimensions of 53 3 43 3 38 Å3, consists of
three domains and has an overall shape resembling a heart
(Fig. 2). The main domain, comprising amino acids 1–14, 94–
192, 220–245, and possibly the C terminus, is composed of a
central six-stranded parallel open twisted b-sheet (b1–b6),
flanked on both sides by in total five a-helices (a5–a8 and a11).
The order of the strands in the b-sheet is b6-b5-b4-b1-b2-b3,
with the strands connected by right-handed b-a-b motifs, ex-
cept for the connection between strands b5 and b6. In the main
domain, three 310-helices are found immediately before and
after strand b3 and before strand b4. The folding motif of the
main domain is generally known as the Rossmann fold (34).
Two subdomains stand out on the C-terminal end of the
central b-sheet: the large atrium of the heart, composed of
residues 15–93 and inserted between strand b1 and helix a5,
has a distorted anti-parallel four-helix-bundle structure. Heli-
ces a1 and a3 are oriented in approximately the same direction,
while the 20-residue long helix a2 and helix a4 are at angles of
135° and 225°, respectively. The helices are connected by short
loops. Two 310-helices mark the start and end of this first
subdomain. In between the main domain and the large atrium,
the active site is located in a cavity with a volume of approxi-
mately 80 Å3. Amino acid residues from the C-terminal end of
strands b4, b1, and b2 make up the bottom of the cavity, and
residues from the four-helix-bundle domain shield the top of
the cavity from the solvent. The second subdomain or small
atrium of the heart is made up by residues 193–219, forming an
excursion of two anti-parallel helices between strands b5 and
b6. This second subdomain is absent in all other L-2-haloacid
dehalogenase sequences found to date. The two helical subdo-
mains are not packed tightly to each other, making only one
direct hydrogen bond. However, both atria are intimately in-
volved in dimerization (see below).
TABLE I
Data collection and MIRAS analysis




Data X31 BW7B X31 X31 X31 X31 Fast Fast
No. of observations 49,346 438,845 20,642 30,247 31,081 52,945 41,312 20,120
Unique reflections 10,198 32,507 5608 4578 4653 7739 4087 4029
Resolution (Å) 2.3 1.95 2.8 3.0 3.0 2.5 3.0 3.0
Completeness (%) 97.0 99.4 98 96 98 98 89 87
Rsym on I (%)
b 6.0 4.2 3.6 2.7 2.8 3.3 7.5 5.8
Rder (%)
c 15.5 13.4 15.0 11.8
MIRAS analysis
Resolution used (Iso/ano) 3.8/3.0 2/3.0 2/3.0 3.8/3.0 3.0/3.5 3.3/5.0
No. of sites 1 3 3 3 2 1
Phasing power (Iso/ano)d 1.0/1.4 2/1.5 2/1.7 1.2/1.6 1.8/1.2 1.1/1.1
Overall figure of merit 0.716
a Ethyl mercurithiosalicylate.
b Rsym 5 ¥h¥iuI(h,i) 2 ^I(h)&u/¥h¥i^I(h)& 3 100%, where I(h,i) is the scaled intensity of the ith observation of reflection h and ^I(h)& is the mean value.
c Rder 5 ¥hu uFPHu 2 uFPu u/¥huFPu 3 100%, where FPH and FP are the structure factors for derivative and native data.
d Phasing power 5 ^FH&/^E&, where ^FH& is the root mean square calculated heavy atom structure factor amplitude and ^E& is the root mean square
lack of closure error; isomorphous and anomalous differences are treated separately.
TABLE II




r.m.s. deviations from ideality for
Bond lengths (Å) 0.009 0.009 0.009
Bond angles (degrees) 2.1 2.0 2.1
Dihedral angles (degrees) 23.8 23.8 23.8
DB for bonded atoms (Å2) 4.9 4.8 4.9
Average B value (Å2) 21.5 21.0 21.3
Final R factor (5.0–1.95 Å, work set) 19.0%
Free R factor (5.0–1.95 Å, 5% test set) 24.8%
Overall R factor (15.0–1.95 Å, all data) 21.3%
Estimated coordinate error (Å)a 0.2
a Derived from a Luzzati plot (32).
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Comparison with Other Dehalogenases—Apart from this L-2-
haloacid dehalogenase, the family of L-2-haloacid dehaloge-
nases comprises eight other members, one haloacetate dehalo-
genase from Moraxella sp. strain B and seven other L-2-
haloacid dehalogenases, all from Pseudomonas species, sharing
36–70% amino acid sequence identity. In 1996, the crystal
structure of L-2-haloacid dehalogenase from Pseudomonas sp.
YL was solved (1) to 2.5 Å. The L-DEX YL has 102 out of its 232
amino acid residues in common with the DhlB sequence, and
its fold is highly similar; 218 of the 220 Ca atoms can be
superimposed with an r.m.s. difference of only 1.3 Å (see Fig. 3).
All residues that were identified to be of importance for the
reaction mechanism are conserved (9) and can be found in
similar positions in the structure of DhlB, although the orien-
tation of the side chains sometimes deviates (see also below).
Despite the similarities, two major differences exist, the first
being the presence of the left atrium subdomain with the two
antiparallel helices a9 and a10. Residues from both helices are
part of the dimer interface, which results in a larger contact
area than in the L-DEX YL enzyme without changing the
overall architecture of the dimer. Second, the active site cavity
of the Xanthobacter structure is shielded from the solvent,
whereas in the Pseudomonas sp. YL enzyme it is open from two
sides.
One entrance to the active site is via a wide open cleft
between the core- and subdomain, which was proposed to ac-
commodate the long alkyl tails of substrates like L-2-bromo-
hexadecanoic acid (1, 35). This entrance is closed in our deha-
logenase, due to 1) a different orientation of the Arg39 side
chain; 2) the position of helix a10, of which residues Phe213 to
Met218 occupy part of space of the L-DEX YL cleft; and 3) a
concerted displacement of about 2 Å of the N- and C-terminal
ends of the large atrium subdomain, causing the side chains of
Tyr10, Asp15, Val16, and Gln17 of helix a1 and Tyr95 of helix a4
to close in on the cleft. This turns the wide canyon of the
Pseudomonas YL enzyme into a narrow, blocked-off tunnel (see
Fig. 4). The deepest point of the tunnel is 5–6 Å away from the
active site cavity.
The second, smaller entrance found in the L-DEX YL struc-
ture is located in between helix a4 and the N termini of helices
a3 and a6. A narrow tunnel leads from there into the active site
cavity, passing along the C termini of strands b1 and b2. In the
Xanthobacter dehalogenase, this entrance is shut by the side
FIG. 1. Stereo view of the active site
with formate ion, displayed with fi-
nal 2Fo 2 Fc OMIT electron density,
contoured at 1s level. Figure was gen-
erated using BOBSCRIPT (40).
FIG. 2. Schematic drawing of the structure of L-2-haloacid de-
halogenase from X. autotrophicus. Strands are shown as arrows
and helices as spirals, with secondary structure elements and termini
labeled. The large atrium comprises helices a1–a4; the small atrium
consists of helices a9 and a10 (this and all following figures were
generated using MOLSCRIPT (41)).
FIG. 3. Superimposition of L-2-haloacid dehalogenase mono-
mers from X. autotrophicus (thick, light shaded lines) and
Pseudomonas sp. YL (thin, darker shaded lines).
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chains of Trp59 and Met120. The latter makes a sulfur-aromatic
interaction with its Sd to the edge of the tryptophan ring. The
corresponding residues in L-DEX YL are a glutamine, which is
directed away from the tunnel, and a serine. Moreover, in DhlB
residues from helices a3 and a4 fill up the tunnel. The different
cavity shapes provide an explanation for the difference in sub-
strate specificity, since the Xanthobacter dehalogenase can
only efficiently degrade short substrates up to the size of L-2-
propionate (8), whereas the Pseudomonas YL enzyme is still
active on, e.g., L-2-bromohexadecanoic acid. The narrow speci-
ficity of DhlB coincides with that of the Xanthobacter haloal-
kane dehalogenase further upstream in the 1,2-dichloroethane
degradation route, which is also limited to short substrates.
Structures of two other dehalogenases have been solved to
date, the 4-chlorobenzoyl-coenzyme A dehalogenase from
Pseudomonas sp. CBS-3 (10) and the haloalkane dehalogenase
from X. autotrophicus (3, 36). The tertiary structure of 4-chlo-
robenzoyl-CoA dehalogenase consists of two domains, with the
active site containing N-terminal main domain comprising two
almost perpendicular mixed b-sheets of in total ten strands,
surrounded by eight a-helices. A C-terminal domain of three
a-helices is involved in trimerization. Thus, its molecular ar-
chitecture is completely different from L-2-haloacid dehaloge-
nase. The haloalkane dehalogenase bears slightly more resem-
blance to the L-2-haloacid dehalogenase. It has a main domain
made up by a central eight stranded mostly parallel b-sheet
surrounded by a-helices with a five helix cap domain on top of
it, creating an active site cavity where dehalogenation takes
place. At closer inspection, the enzymes turn out to be clearly
different; haloalkane dehalogenase is monomeric, the order of
the strands in the b-sheet is different, the location of the active
nucleophile Asp124 is on another strand, and the other two
members of the catalytic triad in haloalkane dehalogenase,
His289 and Asp260, have no counterparts in L-2-haloacid deha-
logenase. Although the fold of the three structurally character-
ized dehalogenases is markedly different, they all dehalogenate
their substrates in a two-step mechanism, with an aspartate
residue as the active nucleophile in the first step of the reaction
(4, 10, 37). This could indicate a general way by which nature
copes with the cleavage of carbon-halogen bonds.
Dimerization—The members of the L-DEX family have been
reported to occur as homodimers (four enzymes, including L-
DEX YL) or homotetramers (one enzyme) (5). To assess the as
yet unknown oligomerization state of DhlB, we performed dy-
namic light scattering experiments, showing that it exists as a
dimer in solution at pH 7.0. Addition of formate decreased the
polydispersity and stabilized the dimer, explaining the indis-
pensability of the additive in crystallization. Both experimen-
tally determined molecular masses, 45 kDa (dynamic light
scattering) and 50 kDa (gel filtration), are close to the calcu-
lated molecular mass of 55 kDa for the dimer.
Mimicking the crystallization conditions stabilized the dimer
already present in solution. Therefore, we assume that the
DhlB crystal structure, with dimensions of 71 3 43 3 56 Å3 for
the dimer, represents the structure of the dimer in solution. Its
two-fold symmetry axis runs nearly parallel to the long helices
a2 (Fig. 5). The enzyme crystallizes in two different space
groups. In the C2221 crystal form, the dimer axis coincides with
a crystallographic two-fold axis, in the P212121 lattice this
exact symmetry is lost. However, the crystal packing is highly
similar and the monomers have largely maintained their sym-
metry. A considerable part of the solvent-accessible surface of
the protein is buried upon dimer formation. The surface area
exposed to solvent amounts to 11,400 Å2/monomer, whereas
the dimer has a solvent-accessible surface of 18,400 Å2, so 19%
of the monomer surfaces is buried. The buried surface is mainly
hydrophobic (67%).
In total, 31 residues per monomer make up the dimerization
interface, contributed nearly exclusively by the two subdo-
mains of the protein. Residues from helices a2 and a3 in the
large atrium and helices a9 and a10 in the small atrium pro-
vide most of the contacts. In addition, a few residues from the
main domain loop following strand b3 and the N-terminal part
of helix a8 are part of the interface. Most of the amino acid
residues involved in dimerization are conserved in the family of
L-2-haloacid dehalogenases (9) or have conservative mutations,
e.g. Tyr/Phe68. DhlB dimerizes in a way very similar to L-DEX
YL, but the small atrium subdomain, which is absent in all
other L-2-haloacid dehalogenases, provides a major contribu-
tion to the dimer interface as 75% of the contacts involve at
FIG. 4. Section of the molecular surfaces of DhlB monomer (left) and L-DEX YL monomer (right). Main chain is represented in black,
and active site is labeled. The orientation is similar to Fig. 2. The closed active site of DhlB is shielded from the solvent by the small atrium.
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least one residue partner located in this subdomain. Conse-
quently, the Xanthobacter dimer is more tightly packed than
the L-DEX YL enzyme, where only 13.5% of the solvent-acces-
sible surface is buried upon dimerization.
From the DhlB structure, it is evident that both active sites
are accessible from the solvent via a narrow cleft. A functional
role for dimerization has not yet been established. Neverthe-
less, it is remarkable to note that the clefts of both monomers
are approximately in line with the two-fold axis relating the
monomers. Since at optimum pH the substrate bears a nega-
tive charge on its carboxylate group, electrostatic interactions
might play a role in pulling the substrate into the active site.
Preliminary electrostatic potential calculations using only
charges on the side chains show that an electrostatic dipole
exists in the dimer. The dipole is directed along the two-fold
axis and thereby into the clefts, with the positive pole inside
the enzyme. This creates an electrostatic force that could pull
substrates in a “carboxylate-first” manner into the active sites
of the dimer. In the separate monomers, a dipole is present too,
but this has a completely different direction and only upon
dimerization is the resulting dipole directed along the two-fold
axis for reasons of symmetry. In L-DEX YL an equivalent
electrostatic dipole is observed in the dimer structure. These
data suggest a role for dimerization in the formation of an
electrostatic dipole that favors substrate import.
Active Site—By 18O-labeled H2O incorporation experiments,
Liu et al. (12) identified an aspartate residue at the C terminus
of strand b1 as the active nucleophile in L-DEX YL. This as-
partate is fully conserved in the family of L-2-haloacid dehalo-
genases, and the equivalent residue in DhlB is Asp8. In the
x-ray structure of Xanthobacter L-2-haloacid dehalogenase, it is
located at the bottom of the closed active site cavity at the
C-terminal end of the b-sheet, in between the main domain and
the four-helix-bundle subdomain. The cavity is lined by atoms
from Asp8, Ala9, Tyr10, Arg39, Leu43, Phe58, Leu113, Ser114,
Asn115, Gly116, Lys147, Asn173, Phe175, and Asp176 (see Fig. 6.
All these amino acids are conserved or show conservative mu-
tations. The geometry of the active site is fixed by an intricate
hydrogen-bonding network, involving all the residues around
the cavity, except for Phe175, which makes aromatic-aromatic
interactions with Phe146 and Tyr10. Inside the cavity, one for-
mate ion (see below) and three water molecules are buried. The
water molecules make hydrogen bonds to Asn173 Nd2, the gua-
nidinium group of Arg39, the carbonyl oxygen of Tyr10, Asp8
Od1, and with each other.
In haloalkane dehalogenase, the active site is also located in
a cavity buried inside the enzyme between the main domain
and the cap domain. Nearly all the amino acids in the haloal-
kane dehalogenase cavity are hydrophobic, with as many as six
aromatic residues that surround the cavity, all serving to ac-
commodate the non-polar substrate 1,2-dichloroethane. Only
the catalytic residues Asp124 and His289 are charged. The sit-
uation is somewhat different in DhlB, as, apart from Asp8, two
more charged residues (Arg39 and Lys147) and several more
polar amino acids (Ser114, Asn115, and Asn173) are found with
their side chains inside the cavity. The functional role of these
residues is discussed below.
Substrate Binding Model and Reaction Mechanism—L-2-
Haloacid dehalogenase is a hydrolytic enzyme with Asp8 as the
active site nucleophile (12). Upon attack of the substrate this
residue forms an ester intermediate (38), which is then hydro-
lyzed by a water molecule. A similar mechanism is observed in
haloalkane dehalogenase (4), where Asp124 is the active nucleo-
phile. The ester intermediate is hydrolyzed by a water molecule
that is activated by His289. Together with Asp260, these two
amino acids form a classic catalytic triad, also found in other
classes of hydrolytic enzymes. From the crystal structure of
L-2-haloacid dehalogenase, it can be seen that such a catalytic
triad is absent, since no histidine is found in the active site.
However, in addition to Asp8, eight polar and charged amino
acids were found to be critical for catalytic activity in the
Pseudomonas sp. YL enzyme (9). As these residues are fully
conserved in the family of L-DEXs, we assume that they have
similar functions in all the members of this family.
In the active site of the DhlB structure, a formate ion is
bound, which we propose to mimic the carboxylate moiety of
the L-2-haloalkanoate substrates (see Fig. 6). The formate C
atom is within 3 Å from the Od1 of the active nucleophile Asp8.
It is held in position by four hydrogen bonds; the formate O1 is
hydrogen-bonded to the backbone amide of Asn115 (2.8,Å), and
formate O2 makes a weak, forked interaction to the backbone
amides of Ala9 (3.0 Å) and Tyr10 (3.1 Å) and a short hydrogen
bond interaction with Ser114 Og (2.6 Å). This explains the
importance of the serine for substrate binding affinity, as ob-
served by Kurihara (9). In contrast, the two positively charged
residues in the active site cavity, Arg39 and Lys147 are not
involved in binding the substrate’s carboxylate group. If the
formate is hypothetically extended by one methyl group to an
acetate, this methyl group is nicely positioned within 2.5 Å of
the Od1 of the nucleophile Asp8, a good distance for nucleo-
philic attack. The other carboxylate oxygen of Asp8 is firmly
held in position by hydrogen bonds to Thr12 Og1, Ser171 Og,
and Asn173 Nd2, all three catalytically critical amino acids.
These residues might make up the oxyanion hole, stabilizing
the negative charge that develops on the Asp8 Od2 upon for-
mation of the tetrahedral intermediate in the hydrolysis step.
Ser171 Og is also within hydrogen-bonding distance of the
Asp176 side chain, which in turn is oriented by Tyr153 Oh. The
other carboxylate oxygen of Asp176 makes a hydrogen bond to
Lys147 Nz. This, together with a hydrogen bond to Leu113 O,
positions the lysine side chain for a third hydrogen-bonding
interaction to Asp8 Od1. The syn lone pair electrons of this
oxygen are now oriented such that they can perform the nu-
cleophilic attack on the substrate. Finally, the only catalyti-
FIG. 5. Stereo view of the L-2-haloacid dehalogenase dimer. The two-fold axis relating the monomers is in the vertical direction.
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cally important residue contributed by the large atrium subdo-
main, Arg39, points straight into the active site. Thus, it makes
a very likely candidate for halide stabilization and abstraction
as it forms a positively charged cradle together with the edges
of the phenyl rings of Tyr10 and Phe175, which is a Trp in all
other L-DEXs. Mutations in both of these aromatic residues
significantly decrease the Pseudomonas enzyme’s activity (9).
If we create a structure-based model of a L-2-chloropropionate
in the active site with the carboxylate group at the formate
position, the chlorine atom fits nicely in this cradle (see Fig. 7).
Halide binding to the guanidinium moiety of arginines and
the edges of aromatic side chains has been observed in halo-
rhodopsin (39) and haloalkane dehalogenase (4), respectively.
In our structure, two water molecules, W52 and W59, are
present at hydrogen-bonding distance from the arginine. The
third water molecule (W100) in the active site is found near
Asp8 Od1 and water W52. The methyl group of the L-2-chloro-
propionate model is close to this position, and binding of the
substrate would force W100 out of the cavity (see Fig. 7). Note
that binding of a D-substrate in a similar way is impossible, as
its alkyl group would clash with main chain and side chain
atoms of Asp8, Ala9, and Tyr10.
In the L-DEX YL enzyme, the orientation of some of the
catalytically important residues in the active site is different as
well as the solvent structure inside the cavity (see Fig. 8). First
of all, the Xanthobacter active site is shielded from the solvent,
mainly because of the extra small atrium subdomain and the
different conformation of the Arg39 side chain. It points
straight into the cavity, thereby closing the tunnel to the sol-
vent. In the Pseudomonas structure, the Arg side chain is
rotated by 160° about x2, away from the active site, making a
long hydrogen bond to Asn173 Od1. In this way, the halide
cradle is disrupted and any interaction with the halogen to be
cleaved off is impossible. It might very well be that the L-DEX
YL arginine side chain changes its conformation upon sub-
strate binding, orienting itself in a similar way as seen in the
Xanthobacter structure. Second, in the DhlB structure a for-
mate ion is present. This possibly induces the Ser114 side chain
to adopt a rotamer state different from the L-DEX YL structure.
The orientation of the substrate that we propose on the basis of
formate binding deviates from the model of Hisano et al. (1), as
they suggest binding of the carboxylate group to the corre-
sponding serine and a water molecule. From our structure, it is
clear that the serine and three main chain amides are involved.
An additional interesting difference is observed for the sur-
roundings of the nucleophile Asp8. The Od2 is bound to Thr12
Og, Ser171 Og, and Asn173 Nd2 in DhlB, whereas the Pseudo-
monas dehalogenase only shows a close interaction between
the aspartate and the serine. Smaller differences are observed
at the bottom of the cleft, where the hydrogen-bonding network
of the Xanthobacter dehalogenase is made up predominantly by
protein-protein interactions, whereas in the Pseudomonas en-
zyme many of the water molecules that are present in its active
site cavity are involved.
The two L-2-haloacid dehalogenase structures, the biochem-
ical data available for L-DEX YL, and the model of L-2-chloro-
propionate binding based on the position of the formate lead us
to suggest the following reaction mechanism; a substrate is
pulled into the active site by electrostatic forces via the cleft
between the main domain and the large atrium subdomain and
FIG. 6. Stereo view of the active site
with solvent structure and formate
ion. The hydrogen bonds are drawn as
dashed lines.
FIG. 7. Stereo view of the model of
L-2-monochloropropionic acid in the
active site based on formate position.
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is bound with its carboxylate group to Ser114 and three main
chain amide groups. The halogen atom is held in position in a
stabilizing halide cradle formed by Arg39, Tyr10, and maybe
also Phe175. Subsequently, at the pH optimum of 9–10, the
negatively charged Asp8 is free to attack the C-2 of the sub-
strate to form an ester intermediate with concurrent cleavage
of the carbon-halogen bond. In the next step, the ester is hy-
drolyzed by a water molecule that attacks on the Cg of Asp8.
The negative charge that develops on the carbonyl oxygen upon
formation of the tetrahedral intermediate is stabilized by the
oxyanion hole made up by Thr12, Ser171, and Asn173. The L-2-
haloacid dehalogenase structures allow us to speculate on the
nature and activation of the hydrolytic water molecule. Lys147
is the most likely candidate for activation of a water molecule,
since its Nz atom is located in a similar position as the Ne2 of
the histidine side chain in the catalytic triad of haloalkane
dehalogenase and its pKa is around the relatively high pH
optimum of L-2-haloacid dehalogenases. In the DhlB structure
with the modeled substrate, however, no water molecules are
found within 4 Å from Asp8 or Lys147, because all three bound
water molecules need to vacate the active site to allow binding
of the substrate. It is possible that an as yet unidentified water
molecule or hydroxyl ion is imported into the active site after
substrate binding or formation of the covalent intermediate,
maybe via the smaller tunnel to the active site.
With the detailed structure of the X. autotrophicus L-2-haloa-
cid dehalogenase complexed with the substrate-analogue for-
mate, substantial new information about this family of deha-
logenases and their substrate binding has become available. It
is evident that further research is needed to elucidate the
complete reaction pathway of dehalogenation in the L-2-haloa-
cid dehalogenases. In particular, three-dimensional structures
of complexes between enzyme and substrates as well as a
structure at the optimum pH could help in obtaining more
information about the hydrolysis step and the enzyme’s stere-
ochemical preferences.
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FIG. 8. Stereo view of the superim-
position of dehalogenase active sites
of X. autotrophicus (thick lines) and
Pseudomonas sp. YL (thin lines). The
formate ion and water molecules are
shown in ball-and-stick representation.
Structure of L-2-Haloacid Dehalogenase33022
